Isolate Data
Patient | Isolate | Region | Year | Species | Subtype | Source | Clone Method |
KDR_pat218 | A0293 | U.S. | 1996 | HIV1 | B | Plasma | None |
Treatment History
Order | Regimen | Weeks |
1 | D4T | 24 |
RT Sequence
NRTIMajorDRMs | NRTIMinorDRMs | NNRTIMajorDRMs | NNRTIMinorDRMs | Polys | UnusualMuts |
V106VI, D123E, K166KR, T200AE, L210F |
>A0293| codons 38-244 CTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQDFWEVQLGIPHP AGLKKKKSITVLDVGDAYFSVPLDKEFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSP AIFQSSMTRILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHREKIEELRQHLFRWGFTTP DKKHQKEPPFLWMGYELHPDKWTVQPI |
Protease Sequence
PIMajorDRMs | PIMinorDRMs | Polys | UnusualMuts |
E35D, N37NS, R57K, L63P |
>A0293| codons 4-99 TLWQRPLVTIKIGGQLKEALLDTGADDTVLEDMSLPGRWKPKMIGGIGGFIKVKQYDQIP IEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNF |
References
Author | Title | Citation |
Kuritzkes, DR | Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimens. | JAIDS, 2004 |
Rhee, SY | HIV-1 protease and reverse transcriptase mutations: Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillance. | J Infect Dis, 2005 |